Peptides: Pfizer

Total Score People Score Events Score
23 23 15
Date Event Presentation Speakers
October 3, 2016 Global Engage's Probiotics Congress: USA Senior Pharma Representatives x1 Arpita Maiti
March 19, 2013 Discovery Chemistry Congress The Future of Formulation and Drug Delivery in Global Healthcare Provision Sven Stegemann
January 12, 2011 Antibodies for the 21st Century Immunoconjugates for Oncology: Fewer Barriers to Delivering Cytotoxicity Now? Alejandro D. Ricart
June 23, 2010 Structure-Based Drug Design An Enriched Structural Kinase Database to Enable Structure-Based Drug Discovery Natasja Brooijmans
May 17, 2010 Phage and Yeast Display of Antibodies and Proteins Determination of the True Diversity of a Human Antibody Library and Insights into the Human Antibody Repertoire, Using Next Generation DNA Sequencing Jaume Pons
September 19, 2009 Nature Chemical Biology Symposium 2009: Chemical Biology in Drug Discovery Session chair: Carolyn Cho
August 26, 2009 Affinity Tag Protein Purification Self-Cleaving Tags Based on Engineered Inteins: Recent Results and Future Prospects David C. Wood
Lore of the Tag: Affinity Purification of Proteases and Kinases Alfredo Tomasselli
Novel Alternatives to Tag-based Affinity Purification Jeffrey S Culp
December 7, 2008 Antibody Engineering Technology Workshops : Using the ProteOn to Characterize Antigen/Antibody Interactions Yasmina Abdiche
December 1, 2008 9th Annual Conference E U R OT I D E S 2008 “20 years of oligonucleotide drug development - what do we have to show?” Arthur M. Krieg
TRACK 1: Immune activation by DNA and RNA, implications for hybridization-based oligo(ribo)nucleotide therapies Jörg Vollmer,
September 16, 2008 Structural Biology and Activation Mechanisms of Membrane Receptors (S1) Evolution of the Insulin/IGF Receptor Systems Robert S Garofalo
April 30, 2008 Assessment of Immunogenicity in Clinical Trials Cell-Based Versus Non-Cell Based Assays to Characterize Neutralizing Antibodies Deborah Finco Kent
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Exploring Chemical Space in Protein-Protein Inhibitor Drug Discovery Tomi Sawyer
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Chairperson's Opening Remarks (08:00-08:15) Ned Mozier
Assessing Structure/Function Relationships (08:15-10:45) Aparna Deora
Assessing Structure/Function Relationships :Protein Changes that Make a Difference: Measuring the Impact on Biopotency with Various Bioanalytical Methods (09:15-09:45) Aparna Deora
Causes and Assessment of Product and Process-Related Impurities (13:25-18:30) Peter J. Nicastro
Causes and Assessment of Product and Process-Related Impurities:Comparison of Techniques for Aggregate Measurement (14:00-14:30) Peter J. Nicastro
CMC Approaches to Specific and Emerging Biotech Products (09:15-10:45) Michael R Schlittler,
CMC Approaches to Specific and Emerging Biotech Products: Characterization of Synthetic Peptides for Biotechnology - Unique Challenges (09:15-09:45) Michael R Schlittler,
Process and Analytical Related Issues (15:30-17:00) Amit Banerjee
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 16: Protein and Peptide Drug Development (13:30-17:00) Anton Fliri, Xing Wang
Session 16: Studies on the Origin of Protein Network Topologies (14:50-15:10) Anton Fliri
Session 16: Analytical Challenges in Protein Therapeutics Development (13:30-13:50) Xing Wang
September 19, 2007 Drug Delivery Global Summit Successful Partnering in the Drug Delivery Market Place James Eshelby
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.